PETALING JAYA: Pharmaceutical company
Hovid Bhd
has received a voluntary offer from its single-largest shareholder to take the company private for a total value of nearly RM243mil, or 38 sen per share.
In a filing with Bursa Malaysia, Hovid announced that Fajar Astoria Sdn Bhd and David Ho Sue San have issued a conditional voluntary takeover offer to acquire all the remaining shares of Hovid not owned by them.
Both parties have also offered to acquire the remaining outstanding warrants of Hovid at 20 sen apiece.
Shares of Hovid were suspended yesterday to make way for the announcement. It will resume trading today.
Ho is the single-largest shareholder of Hovid, with an equity interest of 33.72%. He is also Hovid’s managing director.
Fajar Astoria is a special-purpose vehicle incorporated to undertake the offer with Ho. It was set up by TAEL Two Partners Ltd.
“The joint offerers (Ho and Fajar Astoria) offer to undertake a conditional voluntary takeover offer to acquire 544,085,171 ordinary shares not already held by them, representing about 66.28% of the total shares.
“In addition, the joint offerers wish to acquire 181,841,209 units of outstanding five-year warrants, representing about 56.43% of the total warrants,” the announcement said.
The offer price for the remaining ordinary shares represented a premium of 20.55% to the adjusted five-day volume-weighted average market price (VWAP) of the shares until Oct 6.
As for the warrants, the offer price stood at a premium of 45.02% to the five-day VWAP until Oct 6.
Post-conditional voluntary takeover, both Ho and Fajar Astoria do not intend to maintain the listing status of the pharmaceutical company.
“In the event of the joint offerers receiving acceptances resulting in them holding in aggregate 90% or more of Hovid’s shares, the company will take the requisite steps to withdraw its listing status from the official list of Bursa Securities,” the filing said.
Note that the takeover offer is conditional upon the joint offerers receiving acceptance of not less than 90% of the remaining total shares.
The offer will remain valid for 21 days from the day of filing, unless the joint offerers withdraw the offer with the Securities Commission’s written approval.
